To access this element change to forms mode OFF
Grant Award View - GA65831
Targeting PTP1B to improve adoptive T cell immunotherapy
GA ID:
GA65831
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$671,520.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Targeting PTP1B to improve adoptive T cell immunotherapy
Purpose:
T cells, a subset of specialised white blood cells, play an important role in the clearance of tumours. However, tumours develop complex inhibitory mechanisms, which effectively ‘silence’ T cells and the success of therapies to enhance anti-tumour T cell responses is limited. This proposal will investigate whether the inhibition of an enzyme called PTP1B might enhance T cell responses to help the immune system combating cancer.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1186315
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA